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Abstract
Orbitofrontal alteration in schizophrenia has not been well characterized, likely due to marked
anatomical variability. To investigate the presence of such alterations, we evaluated the sulcogyral
pattern of this ‘H-shaped’ sulcus. Fifty patients with schizophrenia (100 hemispheres) and 50 age-
and gender-matched control subjects (100 hemispheres) were evaluated using 3D high-spatial
resolution MRI. Based on a previous study by Chiavaras and Petrides (2000), the sulcogyral pattern
of the ‘H-shaped’ sulcus, which forms the boundaries of major orbitofrontal gyri, was classified into
three types (Type I, II and III, in order of frequency) within each hemisphere. Chi-square analysis
was performed to compare the sulcogyral pattern, and categorical regression was applied to
investigate clinical/cognitive associations. The control data replicated the orbitofrontal sulcogyral
pattern reported by Chiavaras and Petrides (P = 0.90–0.95), where the distribution was significantly
different between the left and right hemisphere (Type I: right>left, Type II, III: left>right, χ2 = 6.41,
P = 0.041). For schizophrenics, the distribution differed significantly from controls (χ2 = 11.90, P =
0.003), especially in the right hemisphere (χ2 = 13.67, P = 0.001). Moreover, the asymmetry observed
in controls was not present in schizophrenia (χ2 = 0.13, P = 0.94). Specifically, the most frequent
Type I expression was decreased and the rarest Type III expression was increased in schizophrenia,
relative to controls. Furthermore, patients with Type III expression in any hemisphere evinced poorer
socioeconomic status, poorer cognitive function, more severe symptoms and impulsivity, compared
to patients without Type III expression. In contrast, patients with Type I in any hemisphere showed
better cognitive function and milder symptoms compared to patients without Type I. Structurally,
patients with Type III had significantly smaller intra-cranial contents (ICC) volumes than did patients
without Type III (t40 = 2.29, P = 0.027). The present study provides evidence of altered distribution
of orbitofrontal sulcogyral pattern in schizophrenia, possibly reflecting a neurodevelopmental
aberration in schizophrenia. Such altered sulcogyral pattern is unlikely to be due to secondary effects
of the illness such as medication. Moreover, the structural association between Type III and small
ICC volume, observed in the patient group, may suggest that Type III expression could be part of a
systematic neurodevelopmental alteration, given that the small ICC volume could reflect early
reduction of cranial growth driven by brain growth. The observed contrasting association of Type
III expression with poorer outcome, and that of Type I expression with better outcome, further
suggests clinical heterogeneity, and possible differences in treatment responsiveness in
schizophrenia.
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Introduction
Orbitofrontal cortex (OFC) is important for sensory–visceromotor multimodal integration
(Ongur and Price, 2000), as well as for emotional processing and hedonic experience
(Kringelbach, 2005). It is also likely important in the affective evaluation of reinforcers
(rewards and punishers), expectation, motivation, decision-making and goal-directed
behaviour (Gottfried et al., 2003; Holland and Gallagher, 2004; Walton et al., 2004). One
notable feature of OFC is its enormous individual variability at both the level of
cytoarchitecture (especially, granularity) (Ongur and Price, 2000) and gross anatomy
(sulcogyral pattern) (Ono et al., 1990; Chiavaras and Petrides, 2000). In terms of social
neuroscience, OFC figures importantly in emotions and social behaviour, and individual
variability in OFC may be associated with individual differences in personality traits, emotional
processing and behaviour.
Of note here, the social deficit consequences of large orbitofrontal pathological lesions have
long been known (Harlow, 1848), although the association of more subtle anatomical
anomalies of OFC with social behaviour have not been well characterized. Similarly, dating
to the seminal work of Bleuler (1911/1950), the social disturbances of schizophrenia have been
often elegantly described, but the extent to which they may reflect disease-related
neuropathology of the OFC has yet to be established. In the current study, we predict that OFC
will be abnormal in schizophrenia as these patients evince sensory integration and emotional
processing disturbances, which may, in turn, be manifested in the observed hallucinations,
especially for somatic hallucinations, blunted affect, anhedonia, apathy and social dysfunctions
in this disorder.
However, previous MR findings from OFC volume studies have been inconsistent, with some
reporting smaller OFC volume in schizophrenia compared with controls (Gur et al., 2000;
Convit et al., 2001), and others reporting negative findings (Baare et al., 1999; Szeszko et
al., 1999; Chemerinski et al., 2002; Rupp et al., 2005). The large individual variability in OFC
also makes it difficult to define OFC precisely and consistently for both manual ROI and for
voxel-based morphometry (VBM) studies. In fact, the OFC ROI definition has been
inconsistent among previous volume studies (Lacerda et al., 2003), and this variability may be
one of the major reasons for the inconsistent morphometry findings reported for OFC.
Likewise, medication-induced effects may also be a potential confound and are critical to the
interpretation of previous volumetric studies, as (typical) antipsychotics have been reported to
be associated with grey matter volume reduction (Dorph-Petersen et al., 2005; Lieberman et
al., 2005), and mood stabilizers such as lithium and valproate have been reported to increase
grey matter volume, due to their neurotrophic effect (Manji et al., 2000).
Given that the sulcogyral pattern of the brain is formed during neurodevelopment (Armstrong
et al., 1995) and is genetically determined to some extent (Bartley et al., 1997), the sulcogyral
pattern might provide a morphological trait marker to explore morphological alteration,
independent of brain tissue volumes, independent of normal or pathological longitudinal
changes and independent of confounding factors such as medications and chronic illness.
Neurobiologically, the developmental formation of the convolutional sulcogyral pattern, which
is termed gyrogenesis, could reflect neuronal migration, local neuronal connection, synaptic
development, lamination and formation of cytoarchitecture (Rakic, 1988; Armstrong et al.,
1995).
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Previously, our group reported temporal lobe sulcogyral pattern anomalies in schizophrenia
using MR 3D surface rendering (Kikinis et al., 1994). A number of other studies have utilized
the gyrification index (GI) (Zilles et al., 1988), the ratio of the inner and outer cortical surface
contours, to estimate the degree of cortical folding. Using this index, Jou and coworkers as
well as Kulynch and coworkers (Kulynych et al., 1997; Jou et al., 2005), reported decreased
GI (less cortical folding) in the left hemisphere in patients diagnosed with schizophrenia,
although Sallet and coworkers have reported decreased GI in both hemispheres (Sallet et al.,
2003). However, GI in schizophrenia has also been reported to be increased (more cortical
folding) in the right prefrontal region (Vogeley et al., 2000, 2001; Harris et al., 2004a) and in
the right temporal lobe (Harris et al., 2004b). More recently, cortical surface morphology
(geometry), including cortical thickness, surface area and length of sulcal/gyral curvature, have
been evaluated (White et al., 2003). We note here that an essential limitation of methods based
on cortical surface morphology, including cortical folding (GI), is that they are not independent
of brain tissue volume, and are thus potentially unstable over time and susceptible to confounds
affecting brain tissue volume.
Another approach to sulcal morphology is based on measuring the length of a specific sulcus.
This method has been used to evaluate the Sylvian fissure (Falkai et al., 1992; DeLisi et al.,
1994) and the paracingulate sulcus (Yucel et al., 2002; Le Provost et al., 2003). Interestingly,
lack of normal asymmetry in sulcal length is a common feature observed in schizophrenic
populations in these previous studies on sulcal length measurement. Taken together, all of these
previous sulcogyral pattern studies which have applied different methodologies provide
evidence for neurodevelopmental alterations in schizophrenia.
As far as we know, orbitofrontal sulcogyral pattern has not been investigated in schizophrenia.
To investigate the presence of morphological alterations of OFC in schizophrenia, we focused
on the sulcogyral pattern of the ‘H-shaped’ sulcus, which forms the boundary of four major
orbitofrontal gyri including medial, anterior, posterior and lateral orbital gyri (Duvernoy,
1999; Chiavaras and Petrides, 2000). To explore the complexity in OFC anatomy in 50 healthy
volunteers (100 hemispheres), Chiavaras and Petrides (2000) focused on continuity among
medial, lateral and transverse orbital sulci of this ‘H-shaped’ sulcus, rather than the length of
a single sulcus. In the present study, and based on Chiavaras and Petrides' anatomical work,
we classified the OFC sulcogyral pattern into three major types (Type I, II and III in order of
frequency), and we compared their distribution between schizophrenic patients and matched
healthy control subjects. Of particular note, this OFC sulcogyral pattern classification is based
on mutual continuity among neighbouring sulci, and thus is independent of brain tissue volume.
As such, the OFC sulcogyral patterns may reflect a more reliable and valid neurobiological
indicator of regional ‘gyrogenesis’ than cortical surface geometry.
Furthermore, we hypothesized that the difference in OFC sulcogyral pattern may reflect
individual variability in cognitive function (such as abstract thinking, decision-making and
perceptual organization), psychiatric symptomatology (such as hallucination, psychomotor
excitement, disorganized symptom, anhedonia and social deficits) and personality traits (such
as impulsivity or apathy).
In order to explore the significance of OFC sulcogyral pattern in terms of neurodevelopment,
we focused also on intracranial contents (ICC) volume. After controlling for gender and body
size, the magnitude of the adult ICC volume could reflect the early neurodevelopmental phase
of cranial growth process, occurring up to 10–13 years of age (Woods et al., 2005). In
schizophrenics, the ICC volume has been reported to be smaller compared to non-psychiatric
controls (Ward et al., 1996), possibly reflecting early reduction of cranial growth driven by
brain parenchymal growth. We hypothesized that a difference in the OFC sulcogyral pattern
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may be associated with magnitude of the ICC volume as sulcogyral pattern is likely determined
during the early neurodevelopmental phase (Armstrong et al., 1995).
To our knowledge, this is the first study reporting the sulcogyral pattern alteration of this ‘H-
shaped’ sulcus in any brain-related disorder.
Material and methods
Subjects
Fifty patients with schizophrenia and 50 healthy control subjects participated in this study.
Table 1 shows demographic and clinical characteristics of these two groups. All patients were
diagnosed with schizophrenia based on the Diagnostic and Statistical Manual of Mental
Disorders 4th Edition (DSM-IV) criteria, using information from the Structured Clinical
Interview for DSM-III-R (Spitzer et al., 1990b) by trained PhD or MD interviewers. Patients
were recruited from the VA Boston Healthcare System, Brockton Division. All patients were
receiving antipsychotic medication, with a mean daily dose equivalent to 432.0 ± 185.6 mg of
chlorpromazine (Woods, 2003) [typical antipsychotics (8 of the 39 patients, 20.5%), atypical
antipsychotics (26/39, 66.7%), or both (5/39, 12.8%)]. The mean age of patients was 40.6 ±10.4
years, their mean age at symptom onset was 21.3 ± 4.6 years and their mean duration of illness
was 19.5 ± 11.2 years. Control subjects were recruited through newspaper advertisement and
screened using the Structured Clinical Interview (SCID non-patient edition)(Spitzer et al.,
1990a) by the same trained interviewers. No control subjects had an Axis-I psychiatric disorder
or a first-degree relative with Axis-I psychiatric disorder.
Handedness was assessed using the Edinburgh inventory (Oldfield, 1971). Subjects' own and
parental SES were measured by the Hollingshead two-factor index (1 = best, 5 = poorest)
(Hollingshead, 1965), which consists of educational and occupational score. As part of a
comprehensive neuropsychological battery, subjects from both groups were evaluated using
the Wechsler Adult Intelligence Scale (WAIS-III) (Wechsler, 1997) and the WCST (Heaton,
1981), a measure requiring concept formation, abstraction and mental flexibility. Subjects were
group matched for age at MRI scan (P = 0.92), gender (P = 1.0), parental SES (P = 0.20), and
handedness (P = 0.62) (all right-handed). Patients had poorer SES (P<0.0001) and less
education (P<0.0001) and poorer cognitive function than controls, reflecting the debilitating
effects of psychosis. The Positive and Negative Syndrome Scale (PANSS) (Kay et al., 1987)
was administered to patients in order to evaluate clinical symptoms. To investigate personality
traits, the Multidimensional Personality Questionnaire (MPQ) (Tellegen, 1982) was used for
both groups. We note that data for subjects recruited prior to the initiation of MPQ are not
available. Specifically, almost half of the subjects (23 patients and 28 controls) were recruited
prior to use of the MPQ. Moreover, some subjects elected not to participate in some of the
measures. Thus as reflected in degrees of freedom indicated in Table 4, the subject sample
varied for some of the cognitive and clinical assessments. Using a categorical regression model,
we showed that patients' decision to participate in cognitive (F3,46 = 2.21, P = 0.100) or
symptom (F3,46 = 1.76, P = 0.168) assessments was not associated with the sulcogyral pattern.
This study was approved by the VA Boston Healthcare System, partners, and Harvard Medical
School Institutional Review Boards. Written informed consent was obtained from all subjects
prior to study participation.
MRI processing
MR images were acquired with a 1.5-tesla General Electric scanner (GE Medical Systems,
Milwaukee) at the Brigham and Women's Hospital in Boston. The sequence resulted in
contiguous SPGR images (repetition time = 35 ms, echo time = 5 ms, one repetition, 45 degree
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nutation angle, 24-cm field of view, number of excitations = 1.0, matrix = 256 × 256 [192
phase-encoding steps] × 124). Voxels were 0.9375 × 0.9375 × 1.5 mm. Data were formatted
in the coronal plane and analysed as 124 coronal 1.5-mm-thick slices. An anisotropic diffusion
filter was applied to reduce noise prior to processing. For consistent identification of the
sulcogyral pattern, images were realigned using the line between the anterior and posterior
commissures and the midsagittal plane to correct any head tilt, and resampled into isotropic
voxels (0.9375 mm3). The ICC volume was derived from the EM atlas segmentation (Bouix
et al., 2004; Pohl et al., 2004), and included all grey matter, white matter and CSF volumes
above the most inferior axial slice containing cerebellum.
Sulcogyral pattern identification
We based our sulcogyral pattern identification on previous work by Chiavaras and Petrides
(2000). These investigators classified the OFC sulcogyral pattern into three types (Type I, II,
III) in each hemisphere. This visual classification was based on the continuity of the medial
and lateral orbital sulci (MOS, LOS, respectively) (Figs 1 and 2). In Type I, rostral and caudal
portions of the LOS were connected, while the MOS were clearly interrupted between rostral
and caudal portions of MOS. In Type II, rostral and caudal portions of both the MOS and LOS
were connected and continuous MOS and LOS were jointed by the horizontally oriented
transverse orbital sulcus (TOS). In Type III, rostral and caudal portions of both MOS and LOS
were interrupted. Mutual sulcal connectivity was determined by evaluating several axial slices
superior to the most inferior slice where TOS could be observed clearly. To evaluate the
sulcogyral pattern precisely and consistently, neighboring sulci including the olfactory sulcus
(Olf), intermediate orbital sulcus (IOS), posterior orbital sulcus (POS) and sulcus fragmentosus
(Fr) were also identified as landmarks. Of note, Chiavaras and Petrides (2000) reported that
IOS was identified in all of 100 observed hemispheres where 19% showed double IOS (medial
and lateral IOS). POS was observed in 77%, and Fr was observed in only 10% of the 100
hemispheres.
We used a medical image analysis software package [3D slicer, http://www.slicer.org] to
provide reliable classification of the OFC sulcogyral pattern and ICC volume measurement.
The sulcogyral pattern classification in each hemisphere of the 100 subjects was done by M.N.,
blinded to subject group. For assessing interrater reliability, two raters (M.N., T.K.), blinded
to diagnoses, independently evaluated the sulcal pattern for 25 random cases. The intraclass
correlation coefficients (Cronbach's α) were 0.842 for left hemisphere and 0.836 for right
hemisphere.
Statistical analysis
Independent-samples t-tests were performed to assess group differences in demographical data
including age, subjects' own SES, parental SES and handedness. A χ2 test was applied to assess
group differences in gender frequencies.
To evaluate group difference in sulcogyral pattern distribution, a χ2 test was applied to each
hemisphere (n = 50 cases), and also to total number of sulcogyral pattern (n = 100 hemispheres)
when collapsed over hemisphere. The sulcogyral pattern distribution observed in healthy
controls was entered as the expected number for each sulcogyral type (i.e. Type I, II, III). To
specify which type is altered in schizophrenia compared with controls, a χ2 test was also applied
to each sulcal type. To evaluate left-right asymmetry in sulcal pattern distribution, a χ2 test was
applied within each group (n = 50), entering sulcogyral pattern distribution in one hemisphere
as an expected number for the other hemisphere, with the null hypothesis being that sulcogyral
pattern is equal distributed in both hemispheres, based on the original paper (Chiavaras and
Petrides, 2000) showing asymmetric distribution.
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In order to examine the extent to which sulcogyral pattern (a nominal variable) predicted
functional outcome in relation to social, cognitive and symptoms in patients with
schizophrenia, categorical regression analyses were applied rather than multiple regression
analyses. Subjects were classified according to sulcogyral type (e.g., subjects with Type I
versus subjects without Type I sulcogyral pattern), and these three nominal variables (Type I,
II, III) were entered as independent variables in a single model of categorical regression with
each of clinical/cognitive measures entered as a dependent variable within each study group.
We note here that contributions of all three sulcogyral patterns to variance in each dependent
variable (ordinal or interval variable) were tested in a single model of categorical regression,
rather than multiple univariate comparisons, in order to reduce the risk of false positives. When
a covariate was needed for an additional analysis, ordinal regression was performed instead of
categorical regression by applying a covariate.
For cognitive associations, WAIS-III (full-scale IQ), verbal comprehension index, perceptual
organization index, working memory index, processing speed index) and WCST (number of
category completed, total number incorrect, perseverative responses) were used as dependent
variables. We chose a relatively wide-ranging cognitive assessment, as we intended to use these
measures to quantify the relationship of OFC sulcogyral patterns with various aspects of
cognitive domains, which have been linked to the integrity of the prefrontal region. In
particular, multimodal sensory integration, which may be an important contributor to
perceptual organization in WAIS-III, has been associated with orbitofrontal region (Ongur and
Price, 2000), as has perseveration evaluated using the WCST (Freedman et al., 1998). For
clinical associations, not only PANSS total score, but also six PANSS factors of ‘negative’,
‘positive’, ‘disorganized’, ‘excited’, ‘anxiety–depression’ and ‘withdrawn’ were used as
dependent variables (Van den Oord et al., 2006). To investigate the association between OFC
sulcogyral pattern and personality trait, three kinds of broad personality traits of the MPQ
(Tellegen, 1982) were used as dependent variables: ‘Positive Emotionality’ (Wellbeing, Social
Potency and Achievement), ‘Negative Emotionality’ (Stress Reaction, Alienation and
Aggression) and ‘Constraint’ (Control, Harm Avoidance and Traditionalism).
To control for gender in correlation analysis between ICC volume and OFC sulcogyral pattern,
ICC volume from only male subjects was used for analysis because there were only five female
subjects out of 50 subjects in each group. In addition, sometimes a subject had two different
sulcogyral patterns in the two hemispheres, and thus we subdivided subjects into with a
sulcogyral type and without the type (e.g., subjects with Type I versus subjects without Type
I), and compared applying independent sample t-tests. We note that body size information,
such as body height and body weight, was not controlled due to lack of data.
Results
Sulcogyral pattern distribution
Tables 2 and 3, and Figures 3 and 4 show the OFC sulcogyral pattern distribution observed in
each group. In Table 2 and Figure 3, it should be noted that the observed sulcal pattern
distribution in the 50 healthy control subjects was almost identical (P = 0.90–0.95) to that
reported in healthy population by Chiavaras and Petrides (2000), despite the fact that the current
sample of healthy controls is demographically different from the previous study (28 males with
mean age of 25.4 ± 5.3, 22 females with mean age of 24.8 ± 5.3). Of particular interest, within
the healthy control group, the Type I sulcogyral pattern was more frequently expressed in the
right hemisphere, while Type II and III sulcogyral patterns were more frequently expressed in
the left hemisphere (χ2 = 6.41, P = 0.041).
In contrast, the schizophrenia group exhibited a quite different distribution of OFC sulcogyral
pattern. The most infrequent pattern of Type III was expressed in the schizophrenia group with
Nakamura et al. Page 6
Brain. Author manuscript; available in PMC 2009 October 27.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
almost a two-fold increase over the healthy control group (14% versus 25%). A χ2 analysis
revealed that the sulcogyral pattern distribution in the schizophrenia group was significantly
different from that of the healthy control group, in the right hemisphere (χ2 = 13.67, P = 0.001),
and bilateral (left+right) hemispheres (χ2 = 11.90, P = 0.003), but not significant in the left
hemisphere alone (χ2 = 2.23, P = 0.33). Within the right hemisphere, Types I and III showed
group differences (Type I: χ2 = 8.49, P = 0.004, Type III: χ2 = 10.89, P = 0.001), but there was
no significance for Type II (χ2 = 0.89, P = 0.35), indicating that expression was decreased for
Type I and increased for Type III in the schizophrenia group. Within the left hemisphere, there
were no group differences (Type I: χ2 = 0.73, P = 0.40, Type II: χ2 = 0.09, P = 0.77, Type III:
χ2 = 2.17, P = 0.14). When hemisphere was collapsed, Type I and III showed group differences
(Type I: χ2 = 6.80, P = 0.009, Type III: χ2 = 10.05, P = 0.002), but there was no significance
for Type II (χ2 = 0.18, P = 0.67), indicating the same tendency of decreased Type I expression
and increased Type III expression for the patient group.
Moreover, the asymmetrical distribution observed in the healthy control group (χ2 = 6.41, P =
0.041) was not present in the schizophrenia group (χ2 = 0.13, P = 0.94). Table 3 and Figure 4
show the left–right combination of the three sulcal patterns within each group. Note that in the
healthy control group (left/right) combinations of [Type I/Type I] and [Type II/Type I] were
frequently observed in 25 out of 50 control subjects (50%), while these two common
combinations were observed in only 15 patients with schizophrenia (30%). In contrast, the
schizophrenia group exhibited Type III-related combinations more frequently than did the
healthy controls. Especially, combinations of [Type III/Type III] observed in four
schizophrenic patients was never observed in any of the 50 healthy control subjects.
In terms of odds ratio, subjects with Type III sulcogyral pattern in the right hemisphere showed
a 2.84-fold risk for schizophrenia, compared to subjects without a Type III sulcogyral pattern
in the right hemisphere, and subjects with Type I sulcogyral pattern in the right hemisphere
showed a 0.44-fold morbid risk, compared to subjects without Type I sulcogyral pattern in the
right hemisphere. Also, subjects with Type III sulcogyral pattern in any hemisphere showed a
2.05-fold morbid risk, compared to subjects without Type III sulcogyral pattern, and subjects
with Type I sulcogyral pattern in any hemisphere showed a 0.59-fold morbid risk, compared
to subjects without Type I sulcogyral pattern.
Categorical regression analysis of OFC sulcogyral pattern
Demographic data (Table 4)—The OFC sulcogyral pattern was not associated with
subjects' age, gender, handedness, length of illness or chlorpromazine-equivalent antipsychotic
dosage.
Within the schizophrenia group, Type III sulcogyral pattern in any hemisphere was associated
with subjects' own SES (β = 0.49, F = 8.11, P = 0.007), while parental SES was not associated
with any sulcogyral type. A Mann–Whitney U test revealed that SES was higher (poorer) in
patients with Type III sulcogyral pattern than for patients without Type III sulcogyral pattern
(U = 132.0, Z = 3.10, P = 0.002, Fig. 5). Additionally, ordinal regression analysis with parental
SES as a covariate revealed that the positive association between Type III sulcogyral pattern
and subjects' own SES was still significant (Wald = 8.14, P = 0.004), suggesting that the
association was independent of parental SES. Similarly, full-scale IQ (WAIS-III) and total
PANSS score were entered as covariates, and the same association with subjects' own SES was
observed (Wald = 7.49, P = 0.006), suggesting that the association with social disability was
also independent of cognition and clinical symptom severity.
Cognitive measures (Table 4)—Within the schizophrenia group, Type I sulcogyral pattern
(in any hemisphere) was associated with higher scores for the WAIS-III perceptual
organization index (β = 0.44, F = 5.67, P = 0.023), and Type III sulcogyral pattern (in any
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hemisphere) was associated with lower scores in WAIS-III verbal comprehension (β = −0.36,
F = 4.17, P = 0.049). Within the healthy control group, Type I sulcogyral pattern was associated
with higher WAIS-III full scale IQ score (β = 0.53, F = 9.63, P = 0.003) as well as higher scores
for the WAIS-III perceptual organization index (β = 0.55, F = 9.09, P = 0.005). For controls,
Type II sulcogyral pattern was associated with higher levels of perceptual organization (β =
0.48, F = 5.92, P = 0.021) and working memory (β = 0.44, F = 4.65, P = 0.039). Of note, Type
III sulcogyral pattern in controls was associated with frequent perseverative responses in
WCST (β = 0.35, F = 5.39, P = 0.026), although it was also associated with higher scores for
both IQ (β = 0.31, F = 4.36, P = 0.043) and for the WAIS-III working memory index (β = 0.48,
F = 7.46, P = 0.010).
In order to investigate a specific cognitive association commonly observed across the two study
groups with different ranges of IQ, the groups were collapsed covarying total IQ, and then the
ordinal regression analysis was applied to WAIS III indices and WCST. Only working memory
index in WAIS III showed significant findings in that the Type I sulcogyral pattern in both
groups was associated with better performance in working memory compared to subjects
without Type I (Wald = 5.50, P = 0.019).
Clinical measures (Table 4)—Within the schizophrenia group, Type III sulcogyral pattern
corresponded with increased severity of three PANSS factors: positive factor (β = 0.39, F =
4.92, P = 0.032), disorganized factor (β = 0.62, F = 11.51, P = 0.002), and withdrawn factor
(β = 0.53, F = 6.96, P = 0.012). In contrast, Type I corresponded with reduced symptoms ratings
for the PANSS positive factor (β = −0.30, F = 4.28, P = 0.045). Type II sulcogyral pattern also
corresponded with reduced symptom ratings for the PANSS positive factor (β = −0.42, F =
5.73, P = 0.021), but with increased symptom ratings for the PANSS disorganized factor (β =
0.55, F = 9.03, P = 0.005).
Personality trait (Table 4)—Within the schizophrenia group, Type III expression was
negatively associated with the ‘Constraint’ trait (β = −0.68, F = 11.65, P = 0.002), which reflects
tendencies to inhibit impulsivity, unconventional behaviour, and risk-taking, at the high end.
Although ANOVA for hypothesis testing of model fitting was nearly significant (P = 0.055),
Type III expression was positively associated with ‘Negative Emotionality’ trait (β = 0.53, F
= 5.62, P = 0.027), which represents tendencies to experience anxiety, aggression and related
states of negative engagement.
Within the healthy control group, Type II expression was positively associated with ‘Positive
Emotionality’ trait (β=0.83, F=11.59, P=0.003), which represents behavioural and
temperamental tendencies to joy, excitement, vigour and generally to states of positive
engagement. In contrast to Type III expression in the schizophrenia group, Type III expression
in controls was positively associated with ‘Constraint’ tendency (β = 0.57, F=7.03, P = 0.016),
although ANOVA for hypothesis testing only showed a trend-level significance (P = 0.081).
Independence of associations
As the patient group showed associations of the OFC sulcogyral pattern with a broad range of
functional outcome, we subsequently examined the specificity or independence of the
significant associations observed in the initial categorical regression analyses, by applying an
ordinal regression model to the significant findings in the initial categorical regression analyses
within the patient group. After controlling for all other clinical/cognitive measures showing
significant association with the OFC sulcogyral pattern, Type III associations with subjects'
own SES (Wald = 7.67, P = 0.006) and ‘withdrawal’ PANSS factor (Wald = 3.91, P = 0.048)
were still significant while other associations lost significance. Additionally, although the
available data were limited for the MPQ measurement, a negative association between Type
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III and ‘Constraint’ in MPQ, which reflects Type III–impulsivity association, remained
significant (Wald = 4.38, P = 0.036) when controlling for all of the other measures showing
significant associations. These additional analyses suggest that Type III–poor social
functioning associations are more specific and independent than the other significant
associations shown in Table 4.
OFC sulcogyral pattern and intracranial contents volume
ICC volume was significantly smaller in male patients with schizophrenia compared to male
controls (SZ: 1460.7 ± 111.8 cm3, HC: 1509.1 ± 103.7 cm, t84 = 2.08, P = 0.040). Since the
two study groups had different ranges of ICC volumes, analysis was performed within each
group separately. Within the control group, there was no significant difference in ICC volumes
between subjects with and without a specific OFC sulcogyral type. However, within
schizophrenia group, patients with Type III had significantly smaller ICC volumes than patients
without Type III did (t40 = 2.29, P= 0.027, Fig. 5).
Discussion
The present study compared the distribution of OFC sulcogyral patterns in patients with
schizophrenia and age-matched control subjects. Similar to a previous study of healthy
volunteers, findings from the present study demonstrated substantial stability of the OFC
sulcogyral pattern distribution in the current sample of control subjects. That is, controls
manifested almost the identical orbitofrontal sulcogyral pattern reported by Chiavaras and
Petrides (P = 0.90–0.95), where the distribution was significantly different between the left
and right hemisphere (Type I: right>left, Type II, III: left>right, χ2 = 6.41, P = 0.041). This
high concordance between two different healthy samples, in their age ranges (mean age: 25
versus 40 years old), suggests the longitudinal stability of the OFC sulcogyral pattern
distribution following neurodevelopment.
In contrast, the patient group showed a significantly different distribution of sulcogyral patterns
from that of the age-matched control group. First, the patient group did not show the expected
asymmetry in the left and right hemispheres that was observed in the healthy control group.
That is, whereas healthy controls showed greater right than left asymmetry for Type I
expression, and a greater left than right asymmetry for both Type II and Type III expressions,
the patients did not. Of further note, the most frequent Type I expression was decreased and
the rarest Type III expression was increased in schizophrenia, relative to controls, although the
frequency of Type II was almost the same for the two groups. Additionally, within the right
hemisphere, subjects with Type III showed a 2.84-fold risk of being categorized in the patient
group, compared to those without Type III.
The present study thus provides substantial evidence of altered sulcogyral pattern in
orbitofrontal cortex in schizophrenia population. Although longitudinal stability of the
sulcogyral pattern should be confirmed in a future study with longitudinal design, the pattern
is not likely to change over time following neurodevelopment. Further, while one might argue
that longitudinal deterioration in global prefrontal structure might account for changes in the
sulcogyral pattern, we think this unlikely as this pattern is set in neurodevelopment and is
independent of brain tissue volume changes. We thus interpret findings of altered distribution
(increased Type III and decreased Type I) of the sulcogyral pattern in the schizophrenia group
as reflecting a possible risk factor or susceptibility to schizophrenia, rather than secondary to
the effects of illness. Indeed, in the present cross-sectional dataset, the OFC sulcogyral pattern
was not associated with subjects' age at MRI scan, length of the illness, or antipsychotic dosage.
Although the sulcogyral pattern of the ‘H-shaped’ sulcus cannot serve as a diagnostic marker
of schizophrenia, it could provide a morphological trait marker in the ventral prefrontal cortex,
possibly related to a neurodevelopmental variation in the prefrontal paralimbic region.
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OFC sulcogyral pattern and outcome
A further question we had is: within the schizophrenia group, does the OFC sulcogyral pattern
affect patients' outcomes? We tried to address this question using a categorical regression
analysis, which revealed that the least commonly occurring Type III expression in healthy
controls was increased in the schizophrenia group was indeed associated with poorer outcome,
including poor socioeconomic status, poor cognitive performance and more severe clinical
symptoms. In contrast, the most commonly occurring Type I expression in healthy controls,
was decreased in the schizophrenia group, and was associated with better outcome, including
better cognitive performance and mild clinical symptoms. Even in the control group, Type I
expression was associated with better cognitive performance. Type III for the control sample
also was associated with perseveration, which is often viewed as indicative of difficulties in
switching attentional set. However, the meaning of this association is complicated by other
significant correlations with better cognitive performance. Due to the nature of the sulcogyral
pattern, which seems to be stable over time following neurodevelopment, observed clinical
associations with specific sulco-gyral pattern could reflect the heterogeneity (clinical and
biological variability) of schizophrenia, itself, rather than secondary change in the sulcogyral
pattern due to environmental factors linked to clinical outcome.
Type III expression in patients with schizophrenia was also strongly associated with poor
socioeconomic status, consisting of educational and vocational background. This association
is independent of parental socioeconomic status, cognitive function and clinical symptom
severity. Therefore, this might suggest that schizophrenic patients with Type III expression
have more difficulty in social adjustment than patients without Type III expression. Although
the underlying mechanism between brain morphology and social neuroscience should be
further investigated, this morphometric marker could be used as a potential clinical marker in
the field of psychiatric rehabilitation.
Of further note, within each group, the Type I expression was associated with better cognitive
performance, particularly for perceptual organization. In addition, collapsing both groups and
covarying full-scale IQ, Type I expression was associated with better performance in working
memory index.
For clinical symptoms the results also provided evidence linking Type III expression with
poorer outcome and Type I and II expressions with better outcome. Of particular interest,
PANSS symptoms that might capture some of the dimensions of the elusive but disabling social
disturbance of schizophrenia were more closely associated with Type III expression. These
symptoms consisted of passive/apathetic social withdrawal, active social avoidance and
emotional withdrawal, which together form a newly introduced ‘withdrawal’ factor (Van den
Oord et al., 2006). This factor seems to reflect social deficit more specifically than an overall
negative symptom factor. In contrast, Type I and II expressions were associated with milder
symptoms in the positive factor.
For total PANSS score, Type III expression was also associated with higher score (β = 0.45,
F = 5.54, P = 0.024), although ANOVA for hypothesis testing of model fitting was only nearly
significant (P = 0.067). These clinical associations, especially for the positive factor, might at
least partly reflect responsiveness to medication treatment, because all of the present patients
were chronically treated patients (duration of illness was 19.5 years on average), except for
three first-episode patients who were included in the sample. That is, while speculative, the
Type III pattern might be related to more treatment-resistance, and the Type I pattern might
be related to more treatment-effectiveness.
Although available data in MPQ were limited, Type III expression in the schizophrenia group
was negatively associated with ‘Constraint’ and positively associated with ‘Negative
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Emotionality’, both of which might reflect impulsivity, as predicted. These associations evoke
antisocial and disinhibitory personality changes, commonly observed in patients with
ventromedial prefrontal damage or degeneration (Cummings, 1993), although it is difficult to
differentiate intrinsic personality traits from secondary personality changes due to
schizophrenic psychosis. Within controls, Type II was positively associated with the ‘Positive
Emotionality’ trait.
Among the significant functional–anatomical associations in the patient group, the following
three associations of Type III–poor SES (poor social achievement), Type III–severe
‘withdrawal’ PANSS factor (social withdrawal/avoidance), and Type III–less ‘Constraint’
MPQ trait (impulsivity and risk-taking), were found to be more independent and specific than
other significant associations, using ordinal regression analyses. Of particular interest, these
three variables are specifically related to social functioning, suggesting that the Type III
expression may serve as a trait marker for poor social adjustment in schizophrenic population.
Type III expression was also associated with smaller ICC volume in the schizophrenia group,
although body sizes of the two subgroups were unknown. This observation may suggest that
Type III expression was part of a systematic alteration in the early phase of neurodevelopment.
Since adult ICC volume is quite stable over time, this structural association between Type III
expression and smaller ICC volume suggests that the increased expression of Type III is not
associated with the secondary effects of the illness, but is associated with neurodevelopment
(Woods et al., 2005). Additionally, the lack of normal asymmetric distribution observed in the
patient group suggests an alteration in genes that regulate early cortical development, as
evidence suggests genetic involvement in human cerebral cortical asymmetry (Sun et al.,
2005). Finally, this pattern may also reflect individual difference in ‘gyrogenesis’ within OFC,
involved in regional neurobiological properties such as local connectivity and cytoarchitecture
(Armstrong et al., 1995; Rakic, 1988).
Schizophrenic patients with Type III may, therefore, represent a subpopulation of
schizophrenia, which might be characterized by an early neurodevelopmental aberration
together with a more severe clinical picture including social deficit symptoms and poor
treatment response, compared to schizophrenic patients without Type III.
Based on these findings, we view the OFC region, a major part of the social brain, as likely
involved in many neuropsychiatric disorders, including, in particular, schizophrenia, affective
psychosis, obsessive–compulsive disorder, dementia and a broad range of addiction. The OFC
sulcogyral pattern classification could be investigated as a common modulator in social
functioning in these different clinical entities.
Possible caveats
We note a few limitations in our interpretation of the present results. First, the three categorical
sulcogyral patterns were observed across both controls and patients, and we did not include a
non-schizophrenic psychosis group to determine the specificity of the findings to
schizophrenia. Thus the altered sulcogyral pattern distribution should be regarded as a
susceptibility to schizophrenia, but not necessarily as a specific marker for schizophrenia.
Second, Type III expression was associated with poorer social functioning in the patient group
but not in the control group, suggesting a disease-specific association. We caution, however,
that the sample size of controls having Type III is small due to its low expression rate and there
is some missing data for the clinical/cognitive measures, thereby inflating the risk of false
negatives. For these reasons, we think we should be cautious in concluding group specificity
of the poor social functioning–Type III association. Third, interrater reliability of 0.84 for the
sulcogyral pattern classification is high, though not a perfect association, thus suggesting
perhaps some uncertainty in the classification. In reviewing each case, we note that out of the
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50 hemispheres (25 cases), six hemispheres showed a discrepancy between the two raters. More
specifically, three out of the six discrepancies were disagreements between Types I and II, and
the other three were disagreements between Types I and III. In these controversial hemispheres,
the sulcus was disrupted in a few consecutive axial slices and it was connected in a few
consecutive axial slices, which made judgement different between the raters. We point out,
however, that all of the measures were done by one person (M.N.), and the interrater reliability
measures did not change the original determination of Type I, II or III expression. We note
that better spatial resolution of MRI data might reduce this kind of ambiguous pattern.
Conclusion
In conclusion, the present study revealed that the orbitofrontal sulcogyral pattern was altered
in schizophrenic population, where the most frequently expressed Type I was decreased, and
the least frequently expressed Type III was increased in the schizophrenia group, with a lack
of normal asymmetrical distribution of the sulcogyral pattern. Furthermore, within the
schizophrenia group, Type III expression was associated with poorer socioeconomic status,
poorer cognitive function, more severe clinical symptoms (including increased apathy) and
impulsivity as reflected in aggressive and reckless personality traits. In contrast, the Type I
expression was associated with better cognitive function and milder clinical symptoms. The
former was similar to findings in the healthy control group, where the Type I expression was
associated with better cognitive function. These findings, taken together, suggest that the
orbitofrontal sulcogyral pattern could be used as a morphometric trait marker in the fields of
brain research and also clinical neuropsychiatry, and, that for a subset of patients with
schizophrenia, Type III expression might also serve as a predictive marker for poorer social
ability.
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Fig. 1.
‘H-shaped’ sulcus and its variation in human brain. (A) Schema of orbitofrontal sulci and major
gyri.‘H-shaped’ sulcus is traced by red dotted line, dividing orbitofrontal cortex into four gyri
of medial, anterior, posterior and lateral orbital gyri. (B) Example of three sulcal pattern. Three
main orbitofrontal sulcogyral types are defined based on the continuity of the medial and lateral
orbital sulci. Type I expresses most frequently and Type III expresses least frequently in healthy
population. (C) Schema of major three types of sulcal patterns of ‘H-shaped’ sulcus. Olf,
olfactory sulcus; MOS, medial orbital sulcus (-r: rostral, -c: caudal); TOS, transverse orbital
sulcus; LOS, lateral orbital sulcus (-r: rostral, -c: caudal); IOS, intermediate orbital sulcus (-
m: medial, -l: lateral); POS, posterior orbital sulcus; Fr, sulcus fragmentosus. Panels A, B, C
were adapted and modified from a previous paper by Chiavaras and Petrides (see M. M.
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Chiavaras and M. Petrides. Orbitofrontal sulci of the human and macaque monkey brain. J
Comp Neurol 2000; 422: 35–54; reprinted with permission of Wiley-Liss, Inc., a subsidiary
of John Wiley & Sons, Inc.).
Nakamura et al. Page 17
Brain. Author manuscript; available in PMC 2009 October 27.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Fig. 2.
MRI images of major three types of ‘H-shaped’ sulcus. Examples of the major three sulcogyral
patterns from six different subjects. On the axial plane of SPGR (spoiled gradient-recalled
images), sulci of Type I, II, III are delineated with green, blue and pink colour, respectively.
Upper and lower columns demonstrate left and right hemisphere. At this level, olfactory sulcus
cannot be observed in most cases. Sulcal continuities of the medial and lateral orbital sulci
were determined by evaluating several consecutive axial slices rather than just a single slice.
L, left; R, right.
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Fig. 3.
Sulcal pattern distribution of the ‘H-shaped’ sulcus in orbitofrontal cortex. SZ, schizophrenia;
HC, healthy control. Right-sided column shows results from the previous anatomical study
performed by Chiavaras and Petrides (2000).
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Fig. 4.
Sulcal pattern distribution (left and right combination).
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Fig. 5.
Functional and structural association with theType III expression in the patient group. The
higher SES indicates poorer socioeconomic status. The volume of the intracranial contents
(ICC) was computed from total grey matter, white matter and CSF volumes, i.e. above the most
inferior axial slice containing cerebellum.
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